Clinician Preferences for Oxybate Treatment for Narcolepsy: Survey and Discrete Choice Experiment

Overview of attention for article published in Advances in Therapy, May 2023

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
Among the highest-scoring outputs from this source (#21 of 2,732)
High Attention Score compared to outputs of the same age (99th percentile)
High Attention Score compared to outputs of the same age and source (98th percentile)

Mentioned by

news: 36 news outlets

twitter: 1 X user

Readers on

mendeley: 10 Mendeley

So far, Altmetric has seen 36 news stories from 36 outlets.

Survey Highlights Importance of Once-Nightly Oxybate Dosing for Narcolepsy

Pharmacy Times, 13 Jun 2023

A new study found a significantly higher preference for a once-at-bedtime dosing schedule of oxybate treatments for patients…

News story from OZARKSFIRST.com on Tuesday 13 June 2023

OZARKSFIRST.com, 13 Jun 2023

Avadel Pharmaceuticals Announces Publication of Study Data in Advances in Therapy Highlighting Need for Once-at-Bedtime Oxybate Dosing for Narcolepsy

Wlns.com, 13 Jun 2023

DUBLIN, Ireland, June 13, 2023 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a company focused on transforming…

Avadel Pharmaceuticals Announces Publication of Study Data in Advances in Therapy Highlighting Need for Once-at-Bedtime Oxybate Dosing for Narcolepsy

KX News, 13 Jun 2023

DUBLIN, Ireland, June 13, 2023 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a company focused on transforming…

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity, including 32 additional news stories.